Member Info for Owl11

I'm another from the SNG graveyard having foolishly (in hindsight) been "all in".

I've learnt an expensive lesson and have now diversified significantly, although I still hold some SNG I will no longer be as reckless.

Made decent returns so far on this and POG and quite happy to hold long term if necessary.

It's a glitch with Google, seen it many times before. Click on the trades icon and you will see the price has incorrectly reverted to the late reporting of a trade.

It does say Russia describes the talks as constructive (thanks for the link wontongue), which sounds positive of course.

Z & P will only meet once they are very close.

Any links to that Davidol22?

https://www.reuters.com/world/us/ukraine-urges-halt-russias-assault-biden-heads-poland-2022-03-25/

https://twitter.com/AIMdective/status/1506547948603289600?s=20&t=sQjTDcSnKfYFxsoJTfnwMw

Suggest you look again.

It's been amended again back to pause now if you check.

http://www.nih.gov/activ/nih-funded-activ/activ-associated-clinical-trials

I think you're correct Manifesto and with that comes hope and realisation of the potential Activ 2 brings.

https://twitter.com/AIMdective/status/1502211184933621763?s=20&t=GlS3bRzCs3DvazgtS7UwZg

Great spot, that is really good news.

Good clarification and its worth emphasising Activ is TEMPORARILY paused only while they work on trial design to get the best out of SNG, they are obviously encouraged about what they have seen thus far.

https://twitter.com/maxonwifi/status/1499134199919529988?s=20&t=VcKeX4tVNas2mlMCYzza7Q

Synairgen referred Max Bayer to the NIAID statement.

The below link is SAB Biotherapeutics release having graduated to Activ 2 P3 and receiving data.

In simple terms, and my interpretation, is that Activ 2 P2 makes an assessment against virology and safety. P3, having qualified the said, will then attempt to find a practical use for it. I have to say I do get the impression that the team behind Activ are open minded and looking to support as opposed to finding a reason to fail.

Just my thoughts, happy to be corrected.

https://www.globenewswire.com/en/news-release/2022/01/24/2371475/0/en/SAB-Biotherapeutics-Reports-Positive-Phase-2-Virology-Data-Demonstrating-SAB-185-Met-Criteria-for-Advancement-to-Phase-3-in-NIH-ACTIV-2-Trial-for-Treatment-of-COVID-19.html

Thanks Ghia, it's good of you to respond so promptly.

Ghia, thanks for your ongoing contributions to this board, I make a point to look out for your posts and respect your opinions.

Out of interest, if you don't mind me asking, what is your strategy following this weeks disappointments?

Agreed.

https://twitter.com/Neelie001/status/1497182037979156485?s=20&t=fDNfLFJ_WsdN976FOZyqkQ

Not really no.

That's sound advice Sid which I'm sure many wish they had followed to some degree. I sold my entire safe and sensible vanguard funds to put in SNG, it was my decision and I knew the risks but it still stings. I will continue to hold with a genuine belief that all is not lost.